1604610

Risedronate sodium

United States Pharmacopeia (USP) Reference Standard

• Sinônimo(s): Risedronic acid monosodium salt hemi(pentahydrate)
• Fórmula empírica (Notação de Hill): C₇H₁₀NNaO₇P₂ · 2.5H₂O
• Número CAS: 329003-65-8
• Peso molecular: 350.13
• Número MDL: MFCD01706268
• Código UNSPSC: 41116107
• NACRES: NA.24

Propriedades

• grau: pharmaceutical primary standard
• família API: risedronate
• fabricante/nome comercial: USP
• aplicação(ões): pharmaceutical (small molecule)
• formato: neat
• cadeia de caracteres SMILES: OP(C(P(O)([O-])=O)(O)CC1=CC=CN=C1)(O)=O.[Na+]
• InChI: 1S/2C7H11NO7P2.2Na.5H2O/c2*9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;;;;;;;/h2*1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);;;5*1H2/q;;2*+1;;;;;/p-2
• chave InChI: HYFDYHPNTXOPPO-UHFFFAOYSA-L

Descrição

Descrição geral

Risedronate sodium is a member of the pyridinyl class of bisphosphonates. It is mostly used as an antiresorptive agent. It can be used in treating and preventing postmenopausal and glucocorticoid-induced osteoporosis.

Aplicação

Risedronate sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Risedronate Sodium Tablets
• Risedronate Sodium Delayed-Release Tablets

Nota de análise

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Outras notas

Sales restrictions may apply.

Informações de segurança

• Pictogramas: GHS08,GHS07
• Palavra indicadora: Warning
• Frases de perigo: H302,H319,H361,H371
• Declarações de precaução: P202 - P260 - P264 - P301 + P312 - P305 + P351 + P338 - P308 + P311
• Classificações de perigo: Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 2 - STOT SE 2
• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 3
• Ponto de fulgor (°F): Not applicable
• Ponto de fulgor (°C): Not applicable